Thioredoxin in human and experimental sepsis*
- 1 July 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 37 (7), 2155-2159
- https://doi.org/10.1097/ccm.0b013e31819fff67
Abstract
Thioredoxin (TRX) is assumed to be beneficial in acute inflammatory diseases because of its potent antioxidant properties and an inhibitory effect on neutrophil evasion into sites of inflammation. To compare plasma levels of thioredoxin in septic patients and to investigate the role of thioredoxin in a polymicrobial septic mouse model. A combined single-center noninterventional clinical observation study and randomized controlled experimental investigation. Intensive care unit of a university hospital and laboratories of four university hospitals. To evaluate the role of TRX in sepsis, we measured TRX in plasma of septic patients and compared its levels in survivors and patients who did not survive sepsis. In addition, we examined the effect of neutralization of endogenous TRX as well as of treatment with recombinant TRX in a mouse peritonitis model of cecal ligation and puncture (CLP). We found that the serum plasma levels of TRX were significantly higher in patients with sepsis compared with healthy individuals. Furthermore, nonsurvivors showed even higher TRX levels than survivors of sepsis. The CLP septic mouse model revealed that neutralization of endogenous TRX impaired survival of septic mice, whereas treatment with recombinant TRX after CLP strongly enhanced the survival of mice. Our results therefore demonstrate a critical role for TRX in the septic inflammatory response and suggest TRX as a potential therapeutic target for septic shock.Keywords
This publication has 45 references indexed in Scilit:
- Human Thioredoxin-1 Ameliorates Experimental Murine Colitis in Association With Suppressed Macrophage Inhibitory Factor ProductionGastroenterology, 2006
- Extracellular thioredoxin levels are increased in patients with acute lung injuryThorax, 2006
- Protective roles of redox-active protein thioredoxin-1 for severe acute pancreatitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
- Thioredoxin as a Key Molecule in Redox SignalingAntioxidants and Redox Signaling, 2004
- Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in miceHepatology, 2003
- Thioredoxin Blood Level Increases After Severe Burn InjuryAntioxidants and Redox Signaling, 2000
- Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infectionJournal of Hepatology, 2000
- Massive Loss of Sulfur in HIV InfectionAIDS Research and Human Retroviruses, 2000
- Reactive oxygen-reducing and protein-refolding activities of adult t cell leukemia-derived factor /human thioredoxinBiochemical and Biophysical Research Communications, 1992
- APACHE IICritical Care Medicine, 1985